New Technology May Solve Many of Today–s Online Data and Privacy Issues
WorldFlix, on behalf of its subsidiary Paranotek, files patent on new encryption technology
WorldFlix, on behalf of its subsidiary Paranotek, files patent on new encryption technology

SAN JOSE, CA — (Marketwired) — 07/05/17 — AltiGen Communications, Inc. (OTCQB: ATGN), a Silicon Valley based provider of Hosted Skype for Business and Contact Center solutions, will announce its third quarter fiscal year 2017 financial results after the close of regular market trading on Wednesday, July 26, 2017. The Company will also hold a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. ET).What: AltiGen Third Quarter Fiscal Year 2017 Conference Call.When: Wedne

WESTON, FL — (Marketwired) — 07/05/17 — Monaker Group (OTCQB: MKGI) has expanded the total number of instantly-bookable vacation rental properties available through its Monaker Booking Engine (MBE) to approximately 1.4 million units. The new properties are available today via , the industry–s first travel service to offer all ALR properties as instantly bookable.NextTrip is powered by the MBE, a new cloud-based technology platform that delivers ALR reservations that can be instantly confirm

VALENCIA, SPAIN — (Marketwired) — 07/05/17 — Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infa

Highly-Programmable Clock Generator and Jitter Attenuator IC Features sub-200fs Phase Noise to Ease Design Constraints and Lower Total System Costs

SAN JOSE, CA — (Marketwired) — 07/05/17 — AltiGen Communications, Inc. (OTCQB: ATGN), a leading Microsoft Cloud Communications Solutions provider, today announced that Ken Epps and Simon Chouldjian joined AltiGen–s Board of Directors. Mr. Epps and Mr. Chouldjian were elected to the Board at AltiGen–s June 29, 2017 meeting of stockholders.Jeremiah Fleming, AltiGen–s President, CEO and Chairman of the Board said, "We are very pleased to have Ken and Simon join our Board. They each brin

Effects a public listing of an autoimmune biotechnology company with its first drug expected to enter Phase 3 trials in late 2017 for celiac disease with pivotal data expected by first half 2019; Ulcerative colitis phase 2 clinical trials for INN-108 expected to begin in first half 2018

Company To Increase Transparency With Application For Uplist To OTCQB

The letter to the shareholders provides further insight into the company–s products and plans for the future

Award Received in Recognition of Excellent and Consistent Performance and for Supporting Technology Leadership in Mobile Broadband and Evolution to 5G